![[HTML version]](/e/graphics/htmlborder.gif)
![[PDF version]](/e/graphics/pdfborder.gif)
![[CIF]](/e/graphics/cifborder.gif)
![[3d view]](/e/graphics/3dviewborder.gif)
![[Structure Factors]](/e/graphics/structurefactorsborder.gif)
![[CIF check Report]](/e/graphics/checkcifborder.gif)
![[Buy article online]](/logos/buy.gif)
![[Contents scheme]](ng2127contents.gif)
Acta Cryst. (2006). E62, m3101-m3103 [ doi:10.1107/S1600536806044011 ]
-2-(1H-benzoimidazol-2-yl)benzoato-
2N:O]bis{[2-(1H-benzoimidazol-2-yl)benzoato-
2N,O]zinc(II)}Abstract: In the centrosymmetric title compound, [Zn2(C14H9N2O2)4], each ZnII centre is four-coordinated by two N atoms and two O atoms from three 2-(1H-benzoimidazol-2-yl)benzoate ligands in a tetrahedral environment. C-H
O and N-H
O hydrogen bonds stabilize the crystal structure.
Online 27 October 2006
Copyright © International Union of Crystallography
IUCr Webmaster